# Motorcar Parts of America Inc: financial statements, quarterly MPAA · Nasdaq · CIK 918251 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/mpaa.md) · [Financials](/companies/mpaa/financials.md) · [Filings](/companies/mpaa/filings.md) · [Insiders](/companies/mpaa/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mpaa/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [197](/filings/0001140361-24-046159.md) | [172](/filings/0001140361-25-003730.md) | [189 d](/filings/0001140361-26-024463.md) | [170](/filings/0001140361-25-030212.md) | [208](/filings/0001140361-25-041376.md) | [186](/filings/0001140361-26-004387.md) | [193 d](/filings/0001140361-26-024463.md) | [188](/filings/0001140361-26-032013.md) | [221](/filings/0001140361-25-041376.md) | [168](/filings/0001140361-26-004387.md) | [212 d](/filings/0001140361-26-024463.md) | [168](/filings/0001140361-26-032013.md) | | Cost of revenue | $m | [155](/filings/0001140361-24-046159.md) | [142](/filings/0001140361-25-003730.md) | [155 d](/filings/0001140361-26-024463.md) | [141](/filings/0001140361-25-030212.md) | [167](/filings/0001140361-25-041376.md) | [141](/filings/0001140361-26-004387.md) | [155 d](/filings/0001140361-26-024463.md) | [154](/filings/0001140361-26-032013.md) | [179](/filings/0001140361-25-041376.md) | [135](/filings/0001140361-26-004387.md) | [162 d](/filings/0001140361-26-024463.md) | [141](/filings/0001140361-26-032013.md) | | Gross profit | $m | [41.1](/filings/0001140361-24-046159.md) | [30.0](/filings/0001140361-25-003730.md) | [34.8 d](/filings/0001140361-26-024463.md) | [29.2](/filings/0001140361-25-030212.md) | [41.3](/filings/0001140361-25-041376.md) | [44.9](/filings/0001140361-26-004387.md) | [38.5 d](/filings/0001140361-26-024463.md) | [33.9](/filings/0001140361-26-032013.md) | [42.7](/filings/0001140361-25-041376.md) | [32.9](/filings/0001140361-26-004387.md) | [50.4 d](/filings/0001140361-26-024463.md) | [27.2](/filings/0001140361-26-032013.md) | | Research and development | $m | [2.4](/filings/0001140361-24-046159.md) | [2.5](/filings/0001140361-25-003730.md) | [2.6 d](/filings/0001140361-26-024463.md) | [2.4](/filings/0001140361-25-030212.md) | [2.4](/filings/0001140361-25-041376.md) | [3.0](/filings/0001140361-26-004387.md) | [3.5 d](/filings/0001140361-26-024463.md) | [3.3](/filings/0001140361-26-032013.md) | [3.9](/filings/0001140361-25-041376.md) | [3.5](/filings/0001140361-26-004387.md) | [3.5 d](/filings/0001140361-26-024463.md) | [3.2](/filings/0001140361-26-032013.md) | | Operating income | $m | [13.9](/filings/0001140361-24-046159.md) | [9.5](/filings/0001140361-25-003730.md) | [12.2 d](/filings/0001140361-26-024463.md) | [(6.5)](/filings/0001140361-25-030212.md) | [12.5](/filings/0001140361-25-041376.md) | [17.6](/filings/0001140361-26-004387.md) | [16.3 d](/filings/0001140361-26-024463.md) | [20.1](/filings/0001140361-26-032013.md) | [16.4](/filings/0001140361-25-041376.md) | [8.3](/filings/0001140361-26-004387.md) | [21.1 d](/filings/0001140361-26-024463.md) | [3.5](/filings/0001140361-26-032013.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(0.0)](/filings/0001140361-24-046159.md) | [37.3](/filings/0001140361-25-003730.md) | [(1.1) d](/filings/0001140361-26-024463.md) | [(0.2)](/filings/0001140361-25-030212.md) | [0.9](/filings/0001140361-25-041376.md) | [1.1](/filings/0001140361-26-004387.md) | [1.9 d](/filings/0001140361-26-024463.md) | [2.4](/filings/0001140361-26-032013.md) | [3.6](/filings/0001140361-25-041376.md) | [(0.4)](/filings/0001140361-26-004387.md) | [2.3 d](/filings/0001140361-26-024463.md) | [3.4](/filings/0001140361-26-032013.md) | | Net income | $m | [(2.0)](/filings/0001140361-25-003730.md) | [(47.2)](/filings/0001140361-25-003730.md) | [1.3 d](/filings/0001140361-26-024463.md) | [(18.1)](/filings/0001140361-26-004387.md) | [(3.0)](/filings/0001140361-26-004387.md) | [2.3](/filings/0001140361-26-004387.md) | [(0.7) d](/filings/0001140361-26-024463.md) | [3.0](/filings/0001140361-26-032013.md) | [(2.1)](/filings/0001140361-26-004387.md) | [1.8](/filings/0001140361-26-004387.md) | [9.7 d](/filings/0001140361-26-024463.md) | [(13.4)](/filings/0001140361-26-032013.md) | | Diluted EPS | $ per share | [(0.10)](/filings/0001140361-24-046159.md) | [(2.40)](/filings/0001140361-25-003730.md) | not reported | [(0.92)](/filings/0001140361-25-030212.md) | [(0.15)](/filings/0001140361-25-041376.md) | [0.11](/filings/0001140361-26-004387.md) | not reported | [0.15](/filings/0001140361-26-032013.md) | [(0.11)](/filings/0001140361-25-041376.md) | [0.09](/filings/0001140361-26-004387.md) | not reported | [(0.71)](/filings/0001140361-26-032013.md) | | Basic EPS | $ per share | [(0.10)](/filings/0001140361-24-046159.md) | [(2.40)](/filings/0001140361-25-003730.md) | not reported | [(0.92)](/filings/0001140361-25-030212.md) | [(0.15)](/filings/0001140361-25-041376.md) | [0.12](/filings/0001140361-26-004387.md) | not reported | [0.16](/filings/0001140361-26-032013.md) | [(0.11)](/filings/0001140361-25-041376.md) | [0.09](/filings/0001140361-26-004387.md) | not reported | [(0.71)](/filings/0001140361-26-032013.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [10.3](/filings/0001140361-23-052437.md) | [12.2](/filings/0001140361-24-006688.md) | [14.0](/filings/0001140361-25-021940.md) | [7.5](/filings/0001140361-24-036389.md) | [10.4](/filings/0001140361-24-046159.md) | [10.8](/filings/0001140361-25-003730.md) | [9.4](/filings/0001140361-26-024463.md) | [12.5](/filings/0001140361-25-030212.md) | [15.7](/filings/0001140361-25-041376.md) | [17.5](/filings/0001140361-26-004387.md) | [14.7](/filings/0001140361-26-032013.md) | [19.1](/filings/0001140361-26-032013.md) | | Current assets | $m | [588](/filings/0001140361-23-052437.md) | [544](/filings/0001140361-24-006688.md) | [560](/filings/0001140361-25-021940.md) | [540](/filings/0001140361-24-036389.md) | [548](/filings/0001140361-24-046159.md) | [504](/filings/0001140361-25-003730.md) | [511](/filings/0001140361-26-024463.md) | [519](/filings/0001140361-25-030212.md) | [547](/filings/0001140361-25-041376.md) | [558](/filings/0001140361-26-004387.md) | [584](/filings/0001140361-26-032013.md) | [564](/filings/0001140361-26-032013.md) | | Total assets | $m | [1,067](/filings/0001140361-23-052437.md) | [996](/filings/0001140361-24-006688.md) | [1,012](/filings/0001140361-25-021940.md) | [978](/filings/0001140361-24-036389.md) | [986](/filings/0001140361-24-046159.md) | [950](/filings/0001140361-25-003730.md) | [958](/filings/0001140361-26-024463.md) | [973](/filings/0001140361-25-030212.md) | [990](/filings/0001140361-25-041376.md) | [991](/filings/0001140361-26-004387.md) | [1,019](/filings/0001140361-26-032013.md) | [1,010](/filings/0001140361-26-032013.md) | | Current liabilities | $m | [425](/filings/0001140361-23-052437.md) | [390](/filings/0001140361-24-006688.md) | [404](/filings/0001140361-25-021940.md) | [391](/filings/0001140361-24-036389.md) | [394](/filings/0001140361-24-046159.md) | [349](/filings/0001140361-25-003730.md) | [351](/filings/0001140361-26-024463.md) | [361](/filings/0001140361-25-030212.md) | [375](/filings/0001140361-25-041376.md) | [391](/filings/0001140361-26-004387.md) | [400](/filings/0001140361-26-032013.md) | [391](/filings/0001140361-26-032013.md) | | Total liabilities | $m | [742](/filings/0001140361-23-052437.md) | [714](/filings/0001140361-24-006688.md) | [727](/filings/0001140361-25-021940.md) | [711](/filings/0001140361-24-036389.md) | [722](/filings/0001140361-24-046159.md) | [687](/filings/0001140361-25-003730.md) | [700](/filings/0001140361-26-024463.md) | [713](/filings/0001140361-25-030212.md) | [731](/filings/0001140361-25-041376.md) | [733](/filings/0001140361-26-004387.md) | [753](/filings/0001140361-26-032013.md) | [757](/filings/0001140361-26-032013.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [325](/filings/0001140361-23-052437.md) | [282](/filings/0001140361-24-006688.md) | [285](/filings/0001140361-25-021940.md) | [267](/filings/0001140361-24-036389.md) | [264](/filings/0001140361-24-046159.md) | [263](/filings/0001140361-25-003730.md) | [258](/filings/0001140361-26-024463.md) | [260](/filings/0001140361-25-030212.md) | [259](/filings/0001140361-25-041376.md) | [259](/filings/0001140361-26-004387.md) | [266](/filings/0001140361-26-032013.md) | [253](/filings/0001140361-26-032013.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [15.3 d](/filings/0001140361-24-046159.md) | [53.6 d](/filings/0001140361-25-003730.md) | [(9.3) d](/filings/0001140361-26-024463.md) | [(20.8)](/filings/0001140361-25-030212.md) | [22.9 d](/filings/0001140361-25-041376.md) | [34.4 d](/filings/0001140361-26-004387.md) | [9.1 d](/filings/0001140361-26-024463.md) | [10.0](/filings/0001140361-26-032013.md) | [21.9 d](/filings/0001140361-25-041376.md) | [(8.2) d](/filings/0001140361-26-004387.md) | [(4.5) d](/filings/0001140361-26-024463.md) | [(11.3)](/filings/0001140361-26-032013.md) | | Capital expenditure | $m | [0.1 d](/filings/0001140361-24-046159.md) | [0.3 d](/filings/0001140361-25-003730.md) | [0.5 d](/filings/0001140361-26-024463.md) | [0.5](/filings/0001140361-25-030212.md) | [0.6 d](/filings/0001140361-25-041376.md) | [0.7 d](/filings/0001140361-26-004387.md) | [2.9 d](/filings/0001140361-26-024463.md) | [0.8](/filings/0001140361-26-032013.md) | [1.0 d](/filings/0001140361-25-041376.md) | [0.4 d](/filings/0001140361-26-004387.md) | [1.4 d](/filings/0001140361-26-024463.md) | [1.1](/filings/0001140361-26-032013.md) | | Share repurchases | $m | not reported | not reported | [0.0 d](/filings/0001140361-26-024463.md) | [0.0](/filings/0001140361-25-030212.md) | [0.0 d](/filings/0001140361-25-041376.md) | [2.1 d](/filings/0001140361-26-004387.md) | [2.7 d](/filings/0001140361-26-024463.md) | [2.0](/filings/0001140361-26-032013.md) | [1.4 d](/filings/0001140361-25-041376.md) | [5.0 d](/filings/0001140361-26-004387.md) | [3.0 d](/filings/0001140361-26-024463.md) | [1.9](/filings/0001140361-26-032013.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [19.3](/filings/0001140361-23-052437.md) | [19.6](/filings/0001140361-24-006688.md) | [19.5](/filings/0001140361-24-036389.md) | [19.6](/filings/0001140361-24-046159.md) | [19.6](/filings/0001140361-25-003730.md) | [19.7](/filings/0001140361-25-030212.md) | [19.8](/filings/0001140361-25-041376.md) | [20.4](/filings/0001140361-26-004387.md) | [19.9](/filings/0001140361-26-032013.md) | [19.4](/filings/0001140361-25-041376.md) | [20.1](/filings/0001140361-26-004387.md) | [18.9](/filings/0001140361-26-032013.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 18,933,207 at 2026-08-03, from the cover of the [10-Q filed 2026-08-10](/filings/0001140361-26-032013.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.